Class 2 Medicines Recall: Seretide Accuhaler 50 microgram/250 microgram/dose inhalation powder, pre-dispensed.

Glaxo Wellcome UK Limited is recalling one lot of Seretide Accuhaler 50/250mcg because a manufacturing issue has resulted in a small number of units not delivering the full number of doses. (EL (18) A/04)

Click here for further information on this alert.

GSK is also recalling two specific batches of Ventolin (salbutamol) 200mcg Accuhaler devices.

This action follows a manufacturing issue that may result in a small number of Accuhaler devices not delivering the full number of doses in the device.

The Accuhaler, which has a distinctive disk-like shape, is used to treat asthma, but is not widely used in the UK compared to the more commonly used Evohaler

Guidance to help patients identify if their Ventolin Accuhaler is affected by this recall and how to obtain a replacement is provided here.

No other GSK inhalers are affected by this issue, The more commonly used ‘boot’-shaped Ventolin Evohaler ‘rescue’ inhaler is not affected by this recall.



Pfizer outlines training programme for Viagra Connect

Pfizer has announced details of its pharmacy training programme for the POM to P switch Viagra Connect (sildenafil 50mg)

Funding for pharmacists in care homes

NHS England is to fund 180 pharmacists and 60 pharmacy technicians to work in care homes – a move welcomed by the ...